{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:33:51Z","timestamp":1792503231734,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijrobp.2024.12.014","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T12:12:41Z","timestamp":1735819961000},"page":"31-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal Cancer"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7042-7075","authenticated-orcid":false,"given":"Pim J.J.","family":"Damen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Titt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhe","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.N.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.12.014_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0002","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: The randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0003","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12885-016-2564-y","article-title":"ESOPEC: Prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)","volume":"16","author":"Hoeppner","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2016.00020","article-title":"T cells and cancer: How metabolism shapes immunity","volume":"7","author":"Molon","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/cns.12.14","article-title":"Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas","volume":"1","author":"Yovino","year":"2012","journal-title":"CNS Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0008","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.4049\/jimmunol.139.10.3199","article-title":"Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes","volume":"139","author":"Sellins","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI108084","article-title":"A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients","volume":"56","author":"Stratton","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0010","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.3390\/cancers14123024","article-title":"Severe radiation-induced lymphopenia affects the outcomes of esophageal cancer: A comprehensive systematic review and meta-analysis","volume":"14","author":"Dai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0011","first-page":"189","article-title":"Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients","volume":"7","author":"Hyder","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0012","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1634\/theoncologist.2018-0723","article-title":"Lymphopenia in esophageal squamous cell carcinoma: Relationship to malnutrition, various disease parameters, and response to concurrent chemoradiotherapy","volume":"24","author":"Zhou","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0013","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1245\/s10434-019-07334-7","article-title":"Treatment-related lymphopenia predicts pathologic complete response and recurrence in esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy","volume":"26","author":"Li","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0014","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.radonc.2018.02.025","article-title":"High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer","volume":"128","author":"Fang","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0015","article-title":"Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC","volume":"3","author":"Jing","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0016","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1002\/onco.13533","article-title":"Lymphopenia during definitive chemoradiotherapy in esophageal squamous cell carcinoma: Association with dosimetric parameters and patient outcomes","volume":"26","author":"Xu","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","article-title":"The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy","volume":"133","author":"Deng","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0018","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: A systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0019","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.prro.2019.07.010","article-title":"Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: Development and validation of a pretreatment nomogram","volume":"10","author":"van Rossum","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2021.08.009","article-title":"Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: Incidence and external validation of a prediction model","volume":"163","author":"Kroese","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0021","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.1016\/j.ijrobp.2019.06.2041","article-title":"Dose to heart, spine, aorta, and body predict for severe lymphopenia and poor survival in patients undergoing chemoradiation for esophageal cancer","volume":"105","author":"Zhang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0022","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: From enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0023","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/COC.0000000000000206","article-title":"Effects of chemotherapy regimen and radiation modality on hematologic toxicities in patients receiving definitive platinum-based doublet chemoradiation for non-small cell lung cancer","volume":"40","author":"Tang","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0024","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0025","first-page":"15","article-title":"Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy","volume":"22","author":"Abravan","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.intimp.2019.04.032","article-title":"Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC","volume":"72","author":"Guo","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0027","article-title":"Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients\u2019 clinical outcomes","volume":"7","author":"Wang","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0028","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: Analysis of 3 phase 1\/2 trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0029","unstructured":"Anon. Common Terminology Criteria for Adverse Events Version. - Google Scholar. Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Accessed 20 June 2024."},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2021.12.016","article-title":"Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab","volume":"167","author":"Thor","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0031","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2217\/fon-2020-0423","article-title":"Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases","volume":"16","author":"Li","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0032","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3857\/roj.2019.00220","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy","volume":"37","author":"Park","year":"2019","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0033","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-sparing radiotherapy: The rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy","volume":"30","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0036","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0037","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0038","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2017.05.037","article-title":"Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy","volume":"99","author":"Davuluri","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0039","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijrobp.2023.08.058","article-title":"Severe lymphopenia during chemoradiation therapy for esophageal cancer: Comprehensive analysis of randomized phase 2b trial of proton beam therapy versus intensity modulated radiation therapy","volume":"118","author":"Wang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0040","article-title":"Radiation-induced lymphopenia is a causal mediator of survival after chemoradiation therapy for esophagus cancer","volume":"9","author":"Chen","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28136","article-title":"Efficacy and safety in proton therapy and photon therapy for patients with esophageal cancer: A meta-analysis","volume":"6","author":"Zhou","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0042","doi-asserted-by":"crossref","first-page":"N229","DOI":"10.1088\/0031-9155\/54\/12\/N01","article-title":"Integrating a 1.5 T MRI scanner with a 6 MV accelerator: Proof of concept","volume":"54","author":"Raaymakers","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0043","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.prro.2022.11.003","article-title":"Preliminary evaluation of PTV margins for online adaptive radiation therapy of the prostatic fossa","volume":"13","author":"Morgan","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0044","doi-asserted-by":"crossref","first-page":"245ra93","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0045","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.ijrobp.2020.12.004","article-title":"Effect of interleukin-7 on radiation-induced lymphopenia and its antitumor effects in a mouse model","volume":"109","author":"Byun","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0046","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-015-1841-y","article-title":"Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas","volume":"124","author":"Campian","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0047","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S2468-1253(23)00243-1","article-title":"Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (neo-AEGIS): An open-label, randomised, phase 3 trial","volume":"8","author":"Reynolds","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0048","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2022.01.003","article-title":"The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis","volume":"168","author":"Dai","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0049","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0051","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lungcan.2021.01.022","article-title":"Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy","volume":"154","author":"Friedes","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108623","article-title":"Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma","volume":"106","author":"Yin","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0053","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-2669","article-title":"Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: A retrospective analysis","volume":"10","author":"Zhao","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103226","article-title":"Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy","volume":"159","author":"Koukourakis","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2024.12.014_bib0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: A pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624037702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624037702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:51:28Z","timestamp":1762296688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624037702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0360301624037702"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.12.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}